SOTERNEC Trademark

Trademark Overview

On Thursday, January 13, 2022, a trademark application was filed for SOTERNEC with the United States Patent and Trademark Office. The USPTO has given the SOTERNEC trademark a serial number of 79333823. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by Philogen S.p.A.. The SOTERNEC trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for the treatment of cancers; antibodies and antibody derivatives and fragments, namely, human monoclonal antibodies and their derivatives and fragments for medical use; biopharmaceutical preparations for the treatment of cancer of the brain and of soft tissue
soternec

General Information

Serial Number79333823
Word MarkSOTERNEC
Filing DateThursday, January 13, 2022
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7014780
Registration DateTuesday, April 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Goods and ServicesBiopharmaceutical preparations for the treatment of cancers; antibodies and antibody derivatives and fragments, namely, human monoclonal antibodies and their derivatives and fragments for medical use; biopharmaceutical preparations for the treatment of cancer of the brain and of soft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePhilogen S.p.A.
Party Type30 - Original Registrant
Legal Entity Type35 - NOT AVAILABLE
AddressIT
Party NamePhilogen S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type35 - NOT AVAILABLE
AddressIT
Party NamePhilogen S.p.A.
Party Type10 - Original Applicant
Legal Entity Type35 - NOT AVAILABLE
AddressIT

Trademark Events

Event DateEvent Description
Monday, August 14, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 24, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 24, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 19, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 19, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 19, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 19, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 19, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 13, 2022REFUSAL PROCESSED BY IB
Tuesday, May 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 24, 2022REFUSAL PROCESSED BY MPU
Saturday, April 16, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 15, 2022NON-FINAL ACTION WRITTEN
Friday, April 15, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, March 12, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 11, 2022NON-FINAL ACTION WRITTEN
Monday, February 28, 2022ASSIGNED TO EXAMINER
Tuesday, February 22, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 17, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

soternec antibodies fragments biopharmaceutical treatment preparations derivatives cancer brain soft tissue